Are Analysts Bullish about Spire Healthcare Group Plc (LON:SPI) after last week?
22/03/2018 Broker: Berenberg Rating: Buy Old Target: GBX 310.00 New Target: GBX 290.00 Maintain12/03/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 339.00 New Target: GBX 293.00 Maintain05/03/2018 Broker: Barclays Capital Rating: Equal Weight Old Target: GBX 270.00 New Target: GBX 255.00 Maintain05/03/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 339.00 New Target: GBX 339.00 Maintain02/03/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 296.00 New Target: GBX 296.00 Upgrade01/03/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 275.00 New Target: GBX 275.00 Maintain02/02/2018 Broker: Barclays Capital Rating: Equal Weight New Target: GBX 270.00 Initiates Starts26/01/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 270.00 New Target: GBX 275.00 Maintain17/01/2018 Broker: Jefferies Rating: Buy Old Target: GBX 259.00 New Target: GBX 290.00 Upgrade16/01/2018 Broker: Numis Securities Rating: Add New Target: GBX 296.00 Maintain. The stock increased 1.78% or GBX 4 during the last trading session, reaching GBX 229. Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. The firm offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgeries, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat problems; and eye surgery and treatments, family planning, foreign visa medical exams, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart diseases, and kidney disorders.